rdf:type |
|
lifeskim:mentions |
umls-concept:C0030055,
umls-concept:C0043227,
umls-concept:C0128513,
umls-concept:C0149721,
umls-concept:C0205147,
umls-concept:C0439596,
umls-concept:C0443199,
umls-concept:C1280500,
umls-concept:C1517004,
umls-concept:C1522564,
umls-concept:C1999216
|
pubmed:issue |
9
|
pubmed:dateCreated |
1994-12-29
|
pubmed:abstractText |
The aim was to test the hypothesis that local myocardial work and O2 consumption would respond differentially to milrinone, a selective cyclic AMP-phosphodiesterase inhibitor, in left ventricular hypertrophy due to differences in myocardial cyclic AMP-phosphodiesterase activity.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0008-6363
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1360-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7954646-3',5'-Cyclic-AMP Phosphodiesterases,
pubmed-meshheading:7954646-Animals,
pubmed-meshheading:7954646-Aortic Valve Stenosis,
pubmed-meshheading:7954646-Disease Models, Animal,
pubmed-meshheading:7954646-Dogs,
pubmed-meshheading:7954646-Hypertrophy, Left Ventricular,
pubmed-meshheading:7954646-Milrinone,
pubmed-meshheading:7954646-Myocardial Contraction,
pubmed-meshheading:7954646-Myocardium,
pubmed-meshheading:7954646-Oxygen Consumption,
pubmed-meshheading:7954646-Phosphodiesterase Inhibitors,
pubmed-meshheading:7954646-Pyridones
|
pubmed:year |
1994
|
pubmed:articleTitle |
Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
|
pubmed:affiliation |
University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick 08903-0019.
|
pubmed:publicationType |
Journal Article
|